作者: Wen-Xian Li , Hai-Feng Pan , Jian-Li Hu , Chang-Zhong Wang , Ning Zhang
DOI: 10.1007/S10067-009-1322-9
关键词: Endocrinology 、 Lupus erythematosus 、 IL-2 receptor 、 CD8 、 NKG2D 、 Internal medicine 、 Immunology 、 T cell 、 CD3 、 Peripheral blood mononuclear cell 、 Medicine 、 CD16
摘要: This study aims to explore the percentage of T-cell and NK-cell subsets, expression NKG2A NKG2D on CD3+ T cells CD3−CD56+ NK total lymphocytes in new-onset systemic lupus erythematosus (SLE) patients, clinical significance these cell subsets. Thirty-two SLE patients 32 normal controls were enrolled. Flow cytometry was used count T- subsets detect with SLE. Results show that CD4+ (t = 2.04, P < 0.05), CD4+/CD8+ 2.66, CD25+ 2.48, CD3+CD56+ natural killer (NKT) 40.05, 0.01), CD3−CD56+CD16+ 3.50, 0.01) significantly decreased, CD8+ increased 3.80, as compared healthy controls. subset vasculitis 2.47, arthritis 3.21, 0.01). However, no statistically significant correlation found among different PBMC SLEDAI activity scores. Patients had a lower (U 2.42, 0.05) well NKG2A/NKG2D ratio 2.61, higher 2.21, cells, they 2.59, 49.45, 3.05, cells. Taken together, findings indicate decreased T-cell, CD4+CD25+ NKT-, abnormal CD3−CD56 + may play role etiology